Patients’ preferences for genomic diagnostic testing in chronic lymphocytic leukaemia: a discrete choice experiment
Background: Genomic information could help to reduce the morbidity effects of inappropriate treatment decisions in many disease areas, in particular cancer. However, evidence of the benefits that patients derive from genomic testing is limited. This study evaluated patient preferences for genomic te...
Main Authors: | Buchanan, J, Wordsworth, S, Schuh, A |
---|---|
Format: | Journal article |
Published: |
Springer (Adis)
2016
|
Similar Items
-
Using genomic information to guide ibrutinib treatment decisions in chronic lymphocytic leukaemia: a cost-effectiveness analysis
by: Buchanan, J, et al.
Published: (2017) -
What aspects of illness influence public preferences for healthcare priority setting? a discrete choice experiment in the UK
by: Morrell, L, et al.
Published: (2021) -
Do health professionals value genomic testing? A discrete choice experiment in inherited cardiovascular disease
by: Buchanan, J, et al.
Published: (2019) -
Patient preferences for the treatment of chronic cough: a discrete choice experiment
by: Jonathan Schelfhout, et al.
Published: (2024-01-01) -
Progressive multifocal leukoencephalopathy as the presenting feature of chronic lymphocytic leukaemia.
by: Bruce, DR, et al.
Published: (2014)